Radioembolization lung shunt estimation based on a 90Y pretreatment procedure: A phantom study

PURPOSE Prior to 90 Y radioembolization, a pretreatment procedure is performed, in which 99m Tc-macroaggerated albumin (99m Tc-MAA) is administered to estimate the amount of activity shunting to the lungs. A high lung shunt fraction (LSF) may impose lower prescribed treatment activity or even impede treatment. Accurate LSF measurement is therefore important, but is hampered by the use of MAA particles, which differ from 90 Y microspheres. Ideally, 90 Y microspheres would also be used for the pretreatment procedure, but this would require the activity to be lower than an estimated safety threshold of about 100 MBq to avoid unintended radiation damage. However, 90 Y is very challenging to image, especially at low activities (<100 MBq). The purpose of this study was to evaluate the performance of three nuclear imaging techniques in estimating the LSF in a low activity 90 Y pretreatment scan, using an anthropomorphic phantom: (a) positron emission tomography/computed tomography (PET/CT), (b) Bremsstrahlung single photon emission tomography/computed tomography (SPECT/CT), and (c) planar imaging. METHODS The lungs and liver of an anthropomorphic phantom were filled with 90 Y chloride to acquire an LSF of 15%. Several PET/CT (Siemens Biograph mCT), Bremsstrahlung SPECT/CT (Siemens Symbia T16) and planar images (Siemens Symbia T16) were acquired at a range of 90 Y activities (1586 MBq down to 25 MBq). PET images were reconstructed using a clinical protocol (attenuation correction, TOF, scatter and random correction, OP-OSEM), SPECT images were reconstructed using both a clinical protocol (attenuation correction, OSEM) and a Monte Carlo (MC)-based reconstruction method (MC-based detector, scatter, and attenuation modeling, OSEM), for planar images the geometric mean was calculated. In addition, in all cases except clinical SPECT, background correction was included. The LSF was calculated by assessing the reconstructed activity in the lungs and in the liver, as delineated on the CT images. In addition to the 15% LSF, an extra "cold" region was included to simulate an LSF of 0%. RESULTS PET reconstructions accurately estimated the LSF (absolute difference <2 percent point (pp)) when total activity was over 200 MBq, but greatly overestimated the LSF (up to 25pp) when activity decreased. Bremsstrahlung SPECT clinical reconstructions overestimated the LSF (up to 13pp) when activity was both high and low. Similarly, planar images overestimated the LSF (up to 23pp). MC-based SPECT reconstructions accurately estimated the LSF with an absolute difference of less than 1.3pp for activities as low as 70 MBq. CONCLUSIONS Bremsstrahlung SPECT/CT can accurately estimate the LSF for a 90 Y pretreatment procedure using a theoretically safe 90 Y activity as low as 70 MBq, when reconstructed with an MC-based model.

[1]  T. Hellevik,et al.  Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation , 2014, Front. Oncol..

[2]  D. Ganger,et al.  Same-day 90Y radioembolization: implementing a new treatment paradigm , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  H. de Jong,et al.  Quantitative Evaluation of Scintillation Camera Imaging Characteristics of Isotopes Used in Liver Radioembolization , 2011, PloS one.

[4]  Johan Nuyts,et al.  Bias Reduction for Low-Statistics PET: Maximum Likelihood Reconstruction With a Modified Poisson Distribution , 2015, IEEE Transactions on Medical Imaging.

[5]  Marnix G E H Lam,et al.  Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres , 2015, The Journal of Nuclear Medicine.

[6]  P. Xia,et al.  Lung dose calculation with SPECT/CT for ⁹⁰Yittrium radioembolization of liver cancer. , 2013, International journal of radiation oncology, biology, physics.

[7]  Alexander S. Pasciak,et al.  Radioembolization and the Dynamic Role of 90Y PET/CT , 2014, Front. Oncol..

[8]  M. A. van den Bosch,et al.  90Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments , 2015, The Journal of Nuclear Medicine.

[9]  M. Viergever,et al.  99mTc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166Ho-microspheres , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  Jeroen Mertens,et al.  99mTc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with 90Y microspheres , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  A. Rahmim,et al.  Low-dose 90Y PET/CT imaging optimized for lesion detectability and quantitative accuracy: a phantom study to assess the feasibility of pretherapy imaging to plan the therapeutic dose , 2017, Nuclear medicine communications.

[12]  M. A. van den Bosch,et al.  Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study. , 2012, The Lancet. Oncology.

[13]  Max A. Viergever,et al.  Quantitative Monte Carlo–Based 90Y SPECT Reconstruction , 2013, The Journal of Nuclear Medicine.

[14]  D. Townsend,et al.  Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres , 2013, EJNMMI Research.

[15]  Alessandro Radaelli,et al.  Clinical impact of cone beam computed tomography on iterative treatment planning during ultrasound-guided percutaneous ablation of liver malignancies , 2017, Medical Oncology.

[16]  Maurizio Conti,et al.  (90)Y -PET imaging: Exploring limitations and accuracy under conditions of low counts and high random fraction. , 2015, Medical physics.

[17]  L A DeWerd,et al.  A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr. , 2007, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[18]  G. Lucignani,et al.  Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis , 2017, Medical Oncology.

[19]  Abass Alavi,et al.  Insights into the Dose–Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases , 2016, The Journal of Nuclear Medicine.

[20]  C. Bodet-Milin,et al.  Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT , 2013, EJNMMI Research.

[21]  Michael Tapner,et al.  A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  S. Gulec,et al.  Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  Marnix G. E. H. Lam,et al.  Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver Radioembolization , 2013, PloS one.

[24]  J C Hung,et al.  Evaluation of macroaggregated albumin particle sizes for use in pulmonary shunt patient studies. , 2000, Journal of the American Pharmaceutical Association.

[25]  S. Jalkanen,et al.  Nuclear imaging of inflammation: homing-associated molecules as targets , 2013, EJNMMI Research.

[26]  Kathy Willowson,et al.  Quantitative and Qualitative Assessment of Yttrium-90 PET/CT Imaging , 2014, PloS one.

[27]  D. Bailey,et al.  Quantitative (90)Y image reconstruction in PET. , 2012, Medical physics.

[28]  D. Sze,et al.  Radioembolization Dosimetry: The Road Ahead , 2015, CardioVascular and Interventional Radiology.

[29]  Ashfaq Mahmood,et al.  Adsorption of metallic radionuclides on plastic phantom walls. , 2008, Medical physics.

[30]  Jeffrey A. Fessler,et al.  Improved quantitative 90Y bremsstrahlung SPECT/CT reconstruction with Monte Carlo scatter modeling , 2017, Medical physics.

[31]  Max A. Viergever,et al.  elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.

[32]  Marnix G. E. H. Lam,et al.  Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study , 2017, European Radiology.